OOIR: Observatory of International Research

Papers

(The H4-Index of Endocrine is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Contrast CT radiomic features add value to prediction of prognosis in adrenal cortical carcinoma	95
Capecitabine and temozolomide or temozolomide alone in patients with atypical carcinoids	86
Efficacy and safety of iGlarLixi versus insulin glargine in type 2 diabetes: a meta-analysis of randomized controlled trials	82
Thyroid dysfunction in nonvalvular atrial fibrillation and clinical outcomes	79
Impact of age on tumor characteristics and treatment outcomes in pediatric Differentiated Thyroid Carcinoma	65
Prediction model for low bone mass mineral density in type 2 diabetes: an observational cross-sectional study	60
The effect of oral nutrition on diabetic ketoacidosis resolution time: Retrospective Cohort study	56
Consensus nonnegative matrix factorization reveals metastatic gene expression program and identifies E74-like ETS transcription factor 3 confers to the lymph nodes metastasis in papillary thyroid canc	50
The effect of gonadotropin-inhibitory hormone on steroidogenesis and spermatogenesis by acting through the hypothalamic–pituitary–testis axis in mice	48
PTH levels, sleep quality, and cognitive function in primary hyperparathyroidism	46
Temporal decline of sperm concentration: role of endocrine disruptors	46
Radiofrequency ablation for patients with recurrent or persistent secondary hyperparathyroidism after parathyroidectomy: initial experience	42
Mutation screening of eight genes and comparison of the clinical data in a Chinese cohort with congenital hypothyroidism	40
Real-world efficacy and safety of naltrexone-bupropion therapy in Chinese patients with obesity: A single-centre experience	40
Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1–2, 2021	38
Autonomous growth hormone secretion due to McCune Albright syndrome in paediatric age group: an ominous triad	38
The impact of metformin on mortality in patients with type 2 diabetes mellitus: a prospective cohort study	38
Deep learning-based computer-aided diagnosis system for the automatic detection and classification of lateral cervical lymph nodes on original ultrasound images of papillary thyroid carcinoma: a prosp	38
Detection rate and clinical characteristics of coexisting autoimmune diseases in children with Graves’ disease: a single-center study from China	36
Comparative evaluation of ChatGPT-4, ChatGPT-3.5 and Google Gemini on PCOS assessment and management based on recommendations from the 2023 guideline	36
Is melatonin as an ergogenic hormone a myth? a systematic review and meta-analysis	36
Primary tumor resection with or without neck lymph node dissection as a viable initial therapy for medullary thyroid carcinoma with distant metastasis	34
The value of non-punctate echogenic foci in the ultrasonic diagnosis of thyroid nodules	33
Combined LT3 and LT4 therapy for precision medicine: easier with TTCombo system	33
Elevated thyroid-stimulating hormone levels, independent of Hashimoto’s thyroiditis, increase thyroid cancer risk: Insights from genetic and clinical evidence	33

Novel IGFALS mutations with predicted pathogenetic effects by the analysis of AlphaFold structure	32
Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experience	27
Metabolic effects of dopamine-agonists treatment among patients with prolactinomas	27
An unusual brain lesion in a patient with Laron Syndrome	27